Pharmaceutical

FDA warns medical facilities about counterfeit Botox

fda logo FDA warns medical facilities about counterfeit BotoxBatches of Botox shipped from a Canadian drug supplier to more than 350 medical facilities in the United States may be counterfeit and unsafe, the Food and Drug Administration (FDA) warned. The drugs were shipped by suppliers owned by Canada Drugs, a pharmacy that was previously found to have shipped unapproved and counterfeit cancer drugs.

Botox is prescription medication that is injected into muscles and used to treat overactive bladder, chronic migraines, upper limb spasticity, cervical dystonia, certain types of eye muscle problems or abnormal spasm of the eyelids, and excessive underarm sweating. Botox is also used to temporarily improve the look of moderate to severe frown lines between the eyebrows.

The FDA sent a warning letter to doctors about buying drugs from sources other than licensed U.S. pharmacies. The agency said it cannot assure that drugs from these suppliers are approved and thus cannot speak to their safety or effectiveness.

This is the fifth warning the FDA has made this year about foreign suppliers selling drugs to pharmacies that have not been approved by U.S. drug regulators. Earlier this year the agency warned that counterfeit versions of the attention deficit hyperactivity disorder (ADHD) drug Adderall were being sold through the internet. The agency also found two counterfeit cancer drugs, including Avastin, that had been sold to hospitals in the United States. The counterfeit cancer drugs contained none of the active cancer-fighting ingredients.

Source: Times Leader